Should You Buy BioNano Genomics Inc (BNGO) Stock Thursday Morning?

Thursday, August 11, 2022 08:54 AM | InvestorsObserver Analysts

Mentioned in this article

BioNano Genomics Inc (BNGO) is down Thursday morning, with the stock declining -1.33% in pre-market trading to 2.96. BNGO's short-term technical score of 71 indicates that the stock has traded more bullishly over the last month than 71% of stocks on the market. In the Diagnostics & Research industry, which ranks 127 out of 146 industries, BioNano Genomics Inc ranks higher than 84% of stocks. BioNano Genomics Inc has risen 98.68% over the past month, closing at $1.51 on July 14. During this period of time, the stock fell as low as $1.51 and as high as $3.00. BNGO has an average analyst recommendation of Strong Buy. The company has an average price target of $8.25.

BNGO has an Overall Score of 74. Find out what this means to you and get the rest of the rankings on BNGO!
BioNano Genomics Inc has a Long-Term Technical rank of 77. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 23% of the market scoring higher. In the Diagnostics & Research industry which is number 78 by this metric, BNGO ranks better than 78% of stocks.

Important Dates for Investors in BNGO:

-BioNano Genomics Inc is set to release earnings on 11/2/2022. Over the last 12 months, the company has reported EPS of $-0.37. -We do not have a set dividend date for BioNano Genomics Inc at this time. Click Here To Get The Full Report on BioNano Genomics Inc (BNGO)

Share this article: